Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion type Assertion NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_head.
- NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion description "[In a variety of primary tumors, we found RIL methylation in 55 of 92 (60%) cases, with highest methylation in AML and colon cancer, and in 30 of 83 (36%) MDS samples, whereas normal tissues showed either absence or substantially lower levels of methylation, which correlates with age.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_provenance.
- NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion evidence source_evidence_literature NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_provenance.
- NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion SIO_000772 17332327 NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_provenance.
- NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion wasDerivedFrom befree-20140225 NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_provenance.
- NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_assertion wasGeneratedBy ECO_0000203 NP823966.RAeXMzvs1QgKAbLgeK-2KtlLUJ0Koin89VYxNiRBJkeaI130_provenance.